Doctors' travel perks are non-deductible business expenditure when they operate as prohibited promotional inducements.

Expenditure on sponsoring doctors' overseas tours was not deductible under section 37(1) because the trips were found to be inducements to promote the assessee's pharmaceutical products, and the Medical Council ethics regulations prohibit doctors from receiving such travel and hospitality benefits. The claim therefore failed as not wholly and exclusively for business and as expenditure incurred for a prohibited purpose. By contrast, disallowance of physician-sample expenses required factual verification: free samples may be allowable when genuinely used to test efficacy or introduce a product, but the assessee had not furnished sufficient details to show that purpose. The sample issue was therefore sent back for fresh adjudication.

---

---

Issues: (i) Whether expenditure incurred on sponsoring doctors' overseas tours was allowable as business expenditure under section 37(1) of the Income-tax Act, 1961. (ii) Whether disallowance of expenses on physician samples required confirmation or could be sustained in full.

Issue (i): Whether expenditure incurred on sponsoring doctors' overseas tours was allowable as business expenditure under section 37(1) of the Income-tax Act, 1961.

Analysis: The expenditure was held to have been incurred to keep doctors in good humour and to induce prescription of the assessee's pharmaceutical products. The record showed that the trips included travel, hospitality, entertainment and accommodation of doctors and their spouses, while no reliable material established any genuine seminar or knowledge-sharing purpose. Section 37(1) allows only expenditure laid out wholly and exclusively for business, and its Explanation denies deduction for expenditure incurred for any purpose which is an offence or prohibited by law. The Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 prohibit physicians from receiving travel facilities and other benefits from pharmaceutical industry, and such regulations have force of law. The expenditure was therefore treated as unethical, prohibited, and not wholly and exclusively for business.

Conclusion: The disallowance of the overseas tour expenditure was upheld and the assessee's claim failed.

Issue (ii): Whether disallowance of expenses on physician samples required confirmation or could be sustained in full.

Analysis: The Tribunal noted that free samples may be allowable where they are genuinely used at the initial stage to test efficacy and introduce a product in the market, but that position depends on facts and evidence. Here, the assessee had not furnished complete details linking the samples to the stage of product introduction, the recipients, or the business necessity of the distribution. The matter therefore required factual verification as to whether the samples were genuinely for testing efficacy or were in substance sales promotion. In light of the mixed record and the legal distinction between permissible trial samples and impermissible promotional freebies, the issue was not finally concluded on merits against the assessee at this stage.

Conclusion: The issue was remitted to the Assessing Officer for de novo adjudication.

Final Conclusion: The assessee failed on the overseas doctors' tour expenditure, while the physician-sample issue was sent back for fresh decision on the basis of the stated legal distinction and supporting evidence.

Ratio Decidendi: Expenditure connected with benefits or inducements to doctors that are prohibited by medical ethics regulations cannot be deducted under section 37(1), and free physician samples are deductible only when shown to be genuinely necessary for product testing or introduction, not when they function as promotional freebies.

---